Zhang M-B, Ji-Liang H, Li-Fen J, De-Qiang L (2002):
The aim of this study was to determine if exposure to radiofrequency radiation (RFR) had a synergistic effect with Mitomycin C (MMC) in the production of DNA damage in blood lymphocytes. MMC is a drug used in the treatment of cancer that is known to produce DNA damage.
Blood from one male and one female donor was divided into 10 groups:
While the MW exposure did not produce any evidence of DNA or chromosomal damage, the MW+MMC groups showed significantly longer comet lengths than the MMC groups when the concentrations of MMC were 0.025 µg/ml or greater. However, the number of micronuclei was not significantly greater in the MW+MMC groups, compared to the MMC groups alone.